Pharmacologic manipulation of skin pigmentation

Pigment Cell Melanoma Res. 2021 Jul;34(4):777-785. doi: 10.1111/pcmr.12969. Epub 2021 Mar 12.

Abstract

Skin complexion is among the most recognizable phenotypes between individuals and is mainly determined by the amount and type of melanin pigment deposited in the epidermis. Persons with dark skin complexion have more of a brown/black pigment known as eumelanin in their epidermis whereas those with fair skin complexions have less. Epidermal eumelanin acts as a natural sunblock by preventing incoming UV photons from penetrating into the skin and therefore protects against UV mutagenesis. By understanding the signaling pathways and regulation of pigmentation, strategies can be developed to manipulate skin pigmentation to improve UV resistance and to diminish skin cancer risk.

Keywords: cAMP; melanin; melanocortin 1 receptor; melanocyte; pigmentation.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Melanins / metabolism
  • Pharmaceutical Preparations*
  • Skin Pigmentation / drug effects
  • Skin Pigmentation / genetics
  • Skin Pigmentation / physiology*
  • Translational Research, Biomedical

Substances

  • Enzyme Inhibitors
  • Melanins
  • Pharmaceutical Preparations